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Abstract
Background: The promotion of smoking cessation within lung cancer screening could lead to benefits for
smoking-related disease and improve cost-effectiveness of screening. Little is known about how smokers respond
to lung cancer screening and how this impacts smoking behaviour. We aimed to understand how lung cancer
screening influences individual motivations about smoking, including in those who have stopped smoking since
screening.
Methods: Thirty one long-term smokers aged 51–74 took part in semi-structured interviews about smoking. They
had been screened with the EarlyCDT-Lung Test (13 positive result; 18 negative) as part of the Early Cancer Detection
Test Lung Cancer Scotland Study. They were purposively sampled for interview based on their self-reported post-
screening smoking behaviour. Eleven participants had stopped smoking since screening. Verbatim interview transcripts
were analysed using thematic analysis.
Results: Two key overarching themes were interpretations of screening test results and emotional responses to those
interpretations. Participants’ understanding of the risk implied by their test result was often inaccurate, for example a
negative result interpreted as an ‘all-clear’ from lung cancer and a positive result as meaning lung cancer would
definitely develop. Those interpretations led to emotional responses (fear, shock, worry, relief, indifference) influencing
motivations about smoking. Other themes included a wake-up call causing changes in perceived risk of smoking-
related disease, a feeling that now is the time to stop smoking and family influences. There was no clear pattern in
smoking motivations in those who received positive or negative test results. Of those who had stopped smoking,
some cited screening experiences as the sole motivation, some cited screening along with other coinciding
factors, and others cited non-screening reasons. Cues to change were experienced at different stages of the
screening process. Some participants indicated they underwent screening to try and stop smoking, while others
expressed little or no desire to stop.
Conclusions: We observed complex and individualised motivations about smoking following lung cancer screening.
To be most effective, smoking cessation support in this context should explore understanding of screening test results
and may need to be highly tailored to individual emotional responses to screening.
Keywords: Smoking cessation, Early cancer detection, Lung cancer, Teachable moment, Thematic analysis
* Correspondence: fms20@st-andrews.ac.uk
4School of Medicine, University of St Andrews, St Andrews, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Young et al. BMC Public Health         (2018) 18:1276 
https://doi.org/10.1186/s12889-018-6211-1
Background
Tobacco use is responsible for more than five million
deaths a year worldwide [1] and awareness of the link
between smoking and lung cancer is high [2]. Lung can-
cer screening using low-dose computed tomography
(CT) is recommended in the USA for those aged 55–80
with a 30 pack year smoking history [3]. Smokers who
engage in lung cancer screening may be more motivated
to quit [4] and screening could further influence smok-
ing thoughts, motivations and behaviour via a ‘teachable
moment’ or a ‘license to smoke’.
Predictors of attempts to stop smoking include having
made a past quit attempt, lower cigarette dependence,
higher motivation and intention to quit and belief in the
harm caused by smoking [5]. Qualitative research has
further described how health concerns can lead to quit
attempts, often combined with other internal or environ-
mental influences [6]. This work was conducted outside
of the context of lung cancer screening.
Of three randomised lung cancer screening studies that
have compared smoking in screened and control groups,
one observed higher quit rates in the screened group at
2 weeks and at 2 years [7] and two found no long-term ef-
fect of lung cancer screening on smoking [8, 9]. Groups
screened with CT or chest X-ray in the National Lung
Screening Trial reported similar smoking cessation rates
after 3 years [10]. Screened participants who receive an
abnormal screening result appear more likely to quit and
less likely to relapse [7, 10–14]. Increasing rates of smok-
ing cessation in screening patients could lead to benefits
for smoking-related disease and cost-effectiveness of
screening [15]. Professional and medical guidelines
recommend the integration of smoking cessation inter-
ventions into lung cancer screening programmes [16, 17]
although pilot studies of this approach provide mixed
findings of effectiveness [18–22].
There is a lack of evidence on how support should be
provided to most effectively promote smoking abstin-
ence in those screened for lung cancer [23, 24]. In par-
ticular, little is known about how lung cancer screening
influences individual motivations about smoking. Two
studies have used qualitative methods to explore smok-
ing in this context. The first study found that nobody
within a sample of 35 National Lung Screening Trial
participants had stopped smoking more than a year after
screening but some had reduced their smoking. Struc-
tured interviews were used and factors influencing moti-
vations about smoking were not explored in depth [25].
The second study reported three of 37 participants had
quit smoking since screening, one of whom said the
offer of screening had changed their thoughts about
smoking and another said the finding of nodules moti-
vated them to quit [26]. Others reported a lack of
urgency to quit, sometimes citing the monitoring of CT
findings as a reason. To add to this evidence that lung
cancer screening can both increase and decrease motiv-
ation to quit, a qualitative investigation is needed of fac-
tors influencing the motivations of those that decide to
attempt to stop smoking after screening and those that
decide not to. There has been no in-depth study to date
of individuals who have stopped smoking after being
screened for lung cancer.
Based on previous literature on this topic we expected
that lung cancer screening might involve experiences
that in some way promote or inhibit attempts to stop
smoking. The aim of our study is to explore motivations
about smoking in smokers screened for the early detec-
tion of lung cancer, including those who stop smoking
after screening, to better understand how screening im-
pacts motivations to stop or continue smoking and how
cessation support can promote smoking abstinence in
this context.
Methods
Study design
We conducted a qualitative study as part of the Early
Cancer Detection Test - Lung Cancer Scotland (ECLS)
study, a randomised controlled trial evaluating the
effectiveness of a blood test (EarlyCDT-Lung) to detect
lung cancer early [27]. ECLS study participants lived
predominantly in the most deprived areas of the three
study regions of Greater Glasgow and Clyde, Tayside
and Lanarkshire, in Scotland, UK. Participants were at
increased risk of lung cancer due to having at least a 20
pack-year smoking history or a family history of lung
cancer combined with a smoking history representing
an equivalent risk. Blood samples were taken from all
participants and those randomised to the screening arm
were screened for levels of autoantibodies to lung can-
cer, which enabled risk stratification for the targeting of
chest CT scans. Study materials informed participants
that EarlyCDT-Lung detects 40 of every 100 cases of
lung cancer and that eight out of every nine people
receiving a positive test result do not have lung cancer.
Those with a negative test result were notified by a let-
ter stating that between 98 and 99 out of every 100
people with a negative test do not have lung cancer at
the time of the test, and inviting them to contact the
research centre if they have any questions. Those with a
positive test result discussed the implications with a re-
search nurse face-to-face or by telephone. They were
informed the CT scan might detect pulmonary nodules
and that in the majority of people they are of no health
concern. They underwent a chest X-ray and CT scan
and, if lung cancer was not diagnosed, they received
four further CT scans at 6 month intervals. Smokers
did not routinely receive cessation support as part of
the ECLS study in order to prevent stigmatisation as a
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smoker indicated as a potential recruitment barrier by
pre-trial focus groups [28]. However, they could be
asked by the research nurse at their initial visit if they
would like information on smoking cessation or referral
on to an appropriate service. Participants were
reminded of the importance of visiting their general
practitioner if they experience named lung cancer
symptoms.
Recruitment and data collection
We sampled participants for the qualitative study from
a subset of 1043 ECLS study participants taking part in
a nested questionnaire study exploring psychological
and behavioural responses to screening. Questionnaires
collected self-reported data on current smoking status
and recent attempts to stop smoking. A quota sampling
approach was adopted with the aim of recruiting ten
people who had stopped smoking since screening, ten
who had attempted to stop but were still smoking, and
ten who had not attempted to stop. Our definitions for
each category of this sampling frame and other eligibil-
ity criteria are shown in Fig. 1. We aimed to recruit
participants from across two ECLS study regions (Lan-
arkshire had not yet begun recruiting) and participants
who received positive and negative EarlyCDT-Lung re-
sults. This approach was to ensure a diverse range of
screening experiences and behavioural responses were
represented in our sample. Within each quota we took
a convenience sampling approach: eligible individuals
who had most recently returned a follow up question-
naire were sampled in advance of scheduled research
visits. They were sent an invitation letter, information
leaflet and a contact form to return in a prepaid enve-
lope to express interest in taking part. The leaflet ex-
plained that we were investigating what people think
about smoking after lung cancer screening and empha-
sised that the purpose of the study was not to try to
stop them smoking. This aimed to avoid discouraging
those who did not want to stop smoking from taking
part. On return of a contact form a researcher tele-
phoned the participant to explain the study, answer any
questions and arrange a convenient time for an inter-
view. Participants completed a consent form before the
interview. They were advised that the researcher held
no strong feelings about smoking and was simply inter-
ested in their thoughts and feelings. Semi-structured,
face-to-face interviews began with questions about
smoking histories and general ECLS study experiences,
then focused on motivations and decisions made about
smoking since ECLS study enrolment and explored rea-
sons for those. The interview guide is available in Add-
itional file 1. Interviews also covered topics not
reported here: barriers and facilitators to smoking ab-
stinence and attitudes and preferences for smoking ces-
sation support within lung cancer screening. Interviews
were audio recorded and transcribed (anonymised) ver-
batim. All participants were offered a £5 multi-store gift
voucher to thank them for participation. They were
already receiving a series of identical £5 vouchers for
completing the questionnaires so the interview incen-
tive formed part of a larger available remuneration
package.
Fig. 1 Participant flowchart with eligibility criteria and smoker sampling frame definitions
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Analysis
Transcripts were analysed in NVivo software using a
process of inductive and deductive thematic analysis [29,
30]. This involved familiarisation with the data, systematic
coding of data, generation of a set of initial codes, sorting
of codes into structures containing overarching themes and
their subthemes (using separate a priori structures to ad-
dress distinct aims of the research), reviewing and refining
themes and finally, defining and further refining themes to
create a coherent and internally consistent account of the
data. One coder analysed all the data and a second senior
investigator checked samples of transcripts in discussion
with the coder at various points throughout the analysis.
This enabled the revision of codes and their structures and
the development of themes. We continued the coding
process until all data had been systematically coded. During
this process any new concepts identified prompted the re-
view of all interview transcripts to check for the presence of
that concept. We followed the criteria of Seale et al. [31] to
ensure quality of the analysis and write up. We report here
the subset of data relating to motivations about smoking.
Results
Of 12,210 ECLS study participants, 63 were sent an
invitation to the qualitative study, 46 (73%) responded
and 31 (49%) were interviewed (Fig. 1). Based on par-
ticipant preference, 27 interviews took place in partic-
ipants’ homes and four in a private room in a clinical
research facility. Average interview length was 40 min
(range 16–80). Characteristics of participants and of
the source population are shown in Table 1. Inter-
viewees were comparable to the source population on
most characteristics. They were, however, less likely
to live in the most deprived areas and were more
likely to have been intending to stop smoking at
ECLS study enrolment. The timing of interviews in
relation to ECLS study events are shown in Table 2.
Most interviews took place within 5 months of
screening and, for those with a positive result, most
took place before their 6 month ECLS study schedule
CT scan. During their interviews 11 participants re-
ported having stopped smoking since lung cancer
screening. The quotes presented were selected as be-
ing the most succinct and representative data ex-
tract(s) of each theme.
The two key overarching themes extracted in relation
to motivations about smoking were interpretations of
screening test results and emotional responses to those
interpretations.
Interpretations of screening test results
Participants’ interpretations of screening test results
were a perceptual filter through which screening in-
fluenced motivations about smoking. Understanding
of the risk implied by test results was often inaccur-
ate; for example, a negative result interpreted as being
‘all clear’:
P201: And you say ‘well I’ve got a chance, I've not got
it so this would be a good time to stop, I’ve just been
given the all-clear’. (Man,2 56,3 negative,4 not stopped
smoking5)
Here a positive result is interpreted as meaning lung
cancer would definitely develop in the future:
P27: I thought when it was positive that it was there
and it was ‘you’ll get lung cancer,’ I thought that’s the
way it worked. (Woman, 63, positive, stopped
smoking)
Some interpretations demonstrated a more accurate
understanding:
P7: The positive markers were coming up in my blood
and look I read everything and it explained about it
could be a false positive. (Woman, 53, positive,
stopped smoking)
P6: It’s a one in nine chance over the next 2 years ... I
thought well one in nine, that’s roughly the same risk
of one in eight smokers getting lung cancer anyway, it’s
just a pretty short timescale they’ve given me but it’s
pretty good odds. (Woman, 71, positive, stopped
smoking)
Other interpretations involved confusion about the
presence or absence of lung cancer:
P12: I mean to be honest I couldnae [could not]
sit and tell you right now whether I’ve got cancer
or whether I’m getting it. I know I tested positive
for it, so what does that mean? Have I got it, or
am I going to get it? ... But through my own fault
it’s confusing, cause I don’t want to know. So you
just get up every day and continue to smoke cause
you think to yourself, ‘well I’ve probably left it too
late anyway,’ and I’ll just wait and see what
happens next. (Woman, 53, positive, not stopped
smoking)
Emotional responses to interpretations of screening test
results
Emotional responses to the interpretations described
above were central to participants’ motivations about
smoking. These responses included fear, shock, upset,
worry, anxiety and guilt:
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Table 1 Participant and source population characteristics at ECLS study enrolment
Interviewed (n = 31) Source population (n = 376) (screened ECLS study participants
completing follow-up questionnaires who smoked at enrolment)
n (%) [missing] Median Range [missing] n (%) [missing] Median Range [missing]
Age (years) 58
51–74
[0]
59
50–75
[0]
Gender
Man 15 (48.4) 198 (52.7)
Woman 16 (51.6) [0] 178 (47.3) [0]
UK region
Greater Glasgow & Clyde 21 (67.7) 268 (71.3)
Tayside 10 (32.3)
[0]
108 (28.7)
[0]
Ethnicity
White Scottish or White British 30 (100)
[1]
366 (98.4) [4]
Scottish Index of Multiple Deprivation
1 (most deprived quintile) 10 (32.3) 164 (43.7)
2 8 (25.8) 86 (22.9)
3 6 (19.4) 50 (13.3)
4 5 (16.1) 44 (11.7)
5 (least deprived quintile) 2 (6.5) [0] 31 (8.3) [1]
At least one parent or sibling with a lung cancer diagnosis
Yes 6 (19.6) 90 (23.9)
No 25 (80.7) [0] 286 (76.1) [0]
Smoking pack year history 40
20–175
[0]
37
2–175
[0]
Average no. cigarettes smoked a day 15
2–60
[0]
17
0–136
[2]
Attempted to stop smoking in last 6 months
Yes 9 (31.0) 95 (25.8)
No 20 (69.0)
[2]
273 (74.2)
[8]
Intend to stop smoking in next 4 weeks
Yes 10 (32.3) 90 (24.2)
Don’t know 10 (32.3) 100 (26.9)
No 11 (35.5)
[0]
182 (48.9)
[4]
EarlyCDT-Lung result
Positive 13 (41.9) 164 (43.6)a
Negative 18 (58.1)
[0]
212 (56.4)
[0]
aEarlyCDT-Lung results in source population not representative of all ECLS study participants due to higher sampling rate of positive test vs. negative test
participants for questionnaire study
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P7: You don't think there is emotions and fears and
anxieties that come up, you think oh it's a study...
you're facing something that could be possibly
detrimental to you, it can be worrying. For me I think
it really reinforces trying to stop smoking. (Woman, 53,
positive, stopped smoking)
P12: Shocked … shocked but in a round about way … I
remember when I got the letter I was crying. I thought
‘oh my God’ … but then when you go back to the place
they kinda make you feel better, like saying that it’s
nodules and stuff like that. (Woman, 53, positive, not
stopped smoking)
P19: I felt a bit upset, yeh. Not dreadfully because the
nurse I’d spoken to at the hospital said ‘look, it’s not
cut and dried, you may get this message saying that
there’s, you know, positive result but don’t spare’
[despair] type of thing, so I just took it at her word
and sorta went along. (Woman, 74, positive, not
stopped smoking)
P22: I think I feel worse about being a smoker than I
did previously, I’ve always buried my head in the sand
about it ... and it kinda makes it more of a reality and
it actually makes you feel worse about smoking.
Probably more guilty about it actually. (Woman, 59,
positive, not stopped smoking)
Responses to a negative result included relief, reassur-
ance, and indifference:
P10: Thank goodness ... it was just relief because it
come back clear. (Woman, 54, negative, not stopped
smoking)
Some participants experienced a desire to change their
smoking behaviour following screening and some
wanted to continue smoking. Importantly, there were
individual differences in the way in which emotional re-
sponses impacted motivations about smoking, with no
clear pattern according to test results or interpretations
of their meaning. Some were motivated to stop smoking
by a positive test result and felt they would have contin-
ued smoking if the result had been negative. In others
the opposite responses were observed – they were moti-
vated to stop smoking by a negative result but would
have continued smoking if it had been positive.
Interactions between overarching themes and
motivations about smoking
We present three examples that demonstrate the link
between participants’ interpretations of test results,
their emotional responses and their motivations about
smoking. The participant in the first example ex-
plained how her emotional response to the test result
inhibited her ability to understand the risk informa-
tion provided to her and made her too scared to tele-
phone the study centre to ask questions. She
described a vicious circle whereby this emotional re-
sponse and uncertainty led to her smoke more
heavily:
P12: Have I got it [cancer], or am I going to get it?
If I stop smoking will that change, or will I still get
it anyway, because of this gene? So there’s a lot of
questions, you know. And when you go there for
that appointment after it all, you cannae [can not]
really take it in, you know you’re sort of sitting
talking and you think ‘I must remember that, I
must remember that, I must remember that,’ …
and I did get a letter I couldnae [could not] even
tell you where that is.
[...] I’m not quite sure if I’m gonna get cancer or have I
got cancer, but I could phone and ask but I’m kind of
scared to cause I don’t want to know what they’re
gonna say.
I (interviewer): So has that uncertainty affected your
thinking about smoking at all?
P12: Honest to God every time I pick up a cigarette it
comes into my mind. It doesn’t matter what I’m doing,
every cigarette I light I think about it and I think ‘I’m
gonna stop I’m gonna stop I’m gonna stop’ … but I
can’t and it’s like a vicious circle where … because you
cannae [can not] stop thinking about it you’re smoking
more, you know what mean? (Woman, 53, positive,
not stopped smoking)
In the second example (below) the participant’s under-
standing of his negative test result is that it means he
Table 2 Interview timings in the context of the ECLS study
Median
Range
Days since EarlyCDT-Lung screening 146
110–254
Days since EarlyCDT-Lung result letter sent 126
79–228
Positive test participants (n = 13):
Days since ECLS first CT scan 123
72–209
Days before ECLS schedule CT scan (n = 11 [85%]) 58
12–116
Days after ECLS schedule CT scan (n = 2 [15%]) n/a
14; 28
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does not have lung cancer but could still develop the
disease in the future. He experienced relief, elation and
felt lucky. He said this did not change his thoughts
about smoking:
I: Can you remember any time [during the study]
where your thoughts or feelings about smoking
changed at all?
P9: No, I just knew it wasn’t doing me any good, put it
that way. It was doing me harm. … But I was relieved
to learn that I never had lung cancer but it doesn’t
mean to say it wouldn’t recur [occur in the future].
I: Could you tell me a bit more about the relieved
feeling that you had when you found out that your test
was negative? Tell me what that was like when you got
the result?
P9: Obviously a bit elated, you know, but and lucky. …
That’s about it.
I: Why did you feel lucky?
P9: Well that it had missed me out. (Man, 67,
negative, not stopped smoking)
The participant below experienced a ‘fright’ from a
positive test, plus a further fright from a nodule detected
on the subsequent CT scan, described by her as the rea-
son she stopped smoking. Having been a smoker for 40
years, her success at stopping surprised her:
P1: I never thought I would give it up […] so that's
really good.
I: Why did you say you never thought you'd give up?
P1: I don't know I just never thought I would ever stop
smoking cos I've tried and tried at different times. It
just shows you how a fright like that can really make
you stop. And I'm really glad that I went for that
[screening]. [...] I'm really glad I done it now. Cos
that's what's made me stop smoking. Cos I've got
something that's here [in the lung]. I don't even know
what it is. The consultant I've seen said I've got
something here but it's so many centimetres and they
were waiting to see if it grew any more. I had to go
back for another CT scan. That's gave me a real fright
so that is the reason why I did stop. [...]
I: When you found out that your screening test result
was positive, can you tell me how you felt at that
point?
P1: I really got a fright and I didnae [did not] know
am I gonna have lung cancer or is it-- you know-- I
didnae feel good at all. So I was dying to go back
for the CT scan to get that result, to get it all over
and done with. So I was quite down at that time
you know. Well [research nurse] had said to me
that the blood test was positive, wasn't it? That
right? So that even gave me a fright at that. She
said it doesn't mean you've got any lung cancer or
that, but you're in the positive area ... but no, I got
a fright at that time as well.
I: Did you have any thoughts about smoking at that
time?
P1: Yeh. That gave me another trigger to stop, you
know what I mean? I did want to stop then.
I: So at which point did you kind of make that
decision that you were going to try and stop?
P1: Well after I got the result of the CT scan, that
was when I decided that I was definitely going to
do it. So that was a few weeks after I got the result
that I actually stopped, so, I was really really
shocked that there was something there. And I've
not asked the doctor, I'm going to phone up and
ask exactly what this is. I need to phone and ask
does he think it is cancer that's there, do you know
what I mean? He says it's right here at the front of
my lung, but it is only tiny, he said they had to
search the scans to actually find it, so it is tiny, six
whatever, I don't know if it's centimetres or--
(Woman, 54, positive, stopped smoking)
These examples show that individuals’ responses
were different but that their interpretation of their
test result and emotional response were key recurring
themes in their motivations about smoking.
The two overarching themes presented above de-
scribe the key aspects of how screening influenced
motivations about smoking. Further themes presented
below elaborate on aspects of the ‘teachable moment’
represented by screening and important social and
contextual factors influencing motivations about
smoking.
‘Teachable moment’
Theme: A wake-up call
Screening served as a health scare and a wake-up call,
prompting thoughts about the threat of lung cancer.
This was described in terms of an objective confirmation
of the known risks of smoking:
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P22: Most smokers are very sensible people, you know
the risks that you’re taking but it’s a very concrete
thing isn’t it when you get a test result like that, well
it’s concrete in some ways, the reality of what you’re
doing to yourself. (Woman, 59, positive, not stopped
smoking)
Another participant expressed surprise that a positive
result, interpreted as meaning her life was at risk, hadn’t
caused her to decide to stop smoking:
P2: Even after I found out that I did have a positive
result and both lungs have got nodules ... I’m still
smoking! I mean I never ever ever thought that I would
do that. I thought any time when it comes, I’ll have to
make a decision and I’ll make it and that’ll be it, you
know, when my life’s at risk right away I’ll make it and
that’ll be it and I haven’t done that. (Woman, 60,
positive, not stopped smoking)
A participant expressed a desire for the receipt of a
forceful message from a doctor for an even bigger
wake-up call and additional motivation to stop smoking:
P12: All the doctors need to say is, ‘Listen, you. You’ve
came back with a positive result. If you dinnae [do
not] stop smoking today, right now, you’re gonna die.’
(Woman, 53, positive, not stopped smoking)
Theme: Now is the time to stop smoking
Screening created a sense that ‘now’ was the right time
to attempt to stop smoking, although this was not al-
ways acted upon:
P20: I says now I've got the chance to stop it but I
didnae [did not], know what I mean? (Man, 56,
negative, not stopped smoking)
Another participant described being even more deter-
mined to stop after being told that the chest x-ray was
clear:
P5: You stop now before you make it worse. You’re
okay at the moment, you’re not a hundred per cent but
it could be a lot worse. Now’s the time to stop. (Man,
62, negative, stopped smoking)
Social and environmental context
Theme: Family influences
Following screening, family members were influential in
guiding individuals’ motivations about smoking:
P27: The reaction of my family [to the screening
result], in particular my husband, he was so upset, he
was even worse than me to be quite honest with you.
He still never turned round and went like that ‘well
you’re gonna have to stop smoking’ or anything like
that, I done that myself. (Woman, 63, positive,
stopped smoking)
One participant explained how pressure from his wife,
combined with the test result, convinced him to try to
stop smoking:
P29: She’s been on at me for years to stop smoking and
I think a combination of her plus the study plus the
fact that I was lucky enough that it was clear that I
may be chancing my luck if I keep on going. (Man, 70,
negative, stopped smoking)
The offer of information about local smoking cessation
services by research nurses was not mentioned by partic-
ipants during interviews or identified as a theme influen-
cing motivations about smoking.
Contextual factors
There were important non-screening factors influencing
smoking motivations in this sample. These included age
and life stage factors such as becoming a grandparent,
respiratory symptoms, and financial factors. These
themes are described in Table 3 with example quotes.
Coinciding factors
Some said the screening had motivated them to stop
smoking in combination with coinciding non-screening
factors:
P7: Everything sort of fitted in at the right time for me
because ... before I had a wee scare and I kept thinking
‘oh I want to stop smoking’, different things had
happened [family bereavement] and so it all seemed
to— (Woman, 53, positive, stopped smoking)
P6: I felt that the stars were aligned if you like, I had
the Champix [medication to treat nicotine addiction],
I had [smoking cessation counsellor], I had my
granddaughter all as the sort of incentive and I
thought I might never be so lucky again as to get that
that combination of things all at once. It was a
combination of things and I think getting this positive
result in a way was sort of marginal, it may have been
like a sort of final thing. (Woman, 71, positive,
stopped smoking)
Lung cancer screening was a novel experience that, in
combination with other factors, provided an opportunity
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that they felt might not be available again. Screening was
described as having come at the right time and having
‘brought it all in’ and ‘brought it all to a head’ in relation
to other motivating factors.
Of those who did not want to stop smoking there was
often a lack of detail in their accounts of their motiv-
ation to continue smoking as it was not something they
had given much thought. Three themes we extracted
from these participants’ data are described in Table 4
with example quotes.
Cues to change were experienced at different stages of
the screening process, not always immediately following
a test result. Some people already had a desire to stop or
cut down smoking before screening and their screening
experiences either reinforced or did not change these de-
sires (Table 3). Participation in lung cancer screening led
to other smoking behaviour changes, for example several
participants had tried to cut down but had not
attempted to stop. One participant had been prompted
by their screening experiences to begin using filters in
their roll-up cigarettes but had not had any thoughts
about stopping smoking. A diagram of themes is shown
in Fig. 2.
Discussion
This study is the first to our knowledge to explore
in-depth how lung cancer screening influences motiva-
tions to quit smoking and the first to purposively recruit
individuals that have stopped smoking after lung cancer
screening.
Principal findings
Motivations about smoking were closely related to emo-
tional responses to test results, which in turn were
linked to how individuals interpreted these test results,
often inaccurately. Because people had different levels of
understanding about what the test result meant, differ-
ent emotional responses to those understandings and
different pre-existing motivations to change their smok-
ing behaviour, their motivations about smoking were
individualised and difficult to predict. We found positive
and negative results were both experienced as a reason
Table 3 Themes not specific to lung cancer screening and example quotes
Theme Example quotes
Age and life stage P4: As I’ve got older I suppose there is an effect in the sense that it’s all very well saying ‘I’ll carry on smoking’ and then
you die, I’ve been more lately thinking, well yeh but it might be a long painful death.
(Man, 58, negative, not stopped smoking)
P5: My own mortality, reaching 62 and thinking ‘oh you’re nearer the end than you are the beginning now, you’d better
watch what you’re doing,’ that sort of thing. When I go I want to die in my own home, reasonably fit, and I thought if
I keep smoking that might not happen. When you start reflecting and you get near the age you were when they [participant’s
parents] died and you think ‘maybe it’s time you stopped’. (Man, 62, negative, stopped smoking)
P6: My first grandchild was expected. I just did not want to be a smoking granny. (Woman, 71, positive, stopped smoking)
Respiratory symptoms Interviewer: Can you remember what made you decide to try and stop back in January?
P26: Because truthfully it’s my health, it’s my health. Cos like I don’t feel ill, it was more when I lay in my bed at night I could
hear myself wheezing and I said ‘need to give up these cigarettes I’m gonna end up really ill,’ and you know? And I think that
was one of the reasons. (Woman, 57, negative, not stopped smoking)
Money P4: My motivation in trying to stop smoking was really financial. It’s now something like seven pound fifty a packet, incredible
price you know, so that that was the real motivator I have to say. (Man, 58, negative, not stopped smoking)
P18: The main reason I would like to stop is the money aspect, cos it is very very expensive and I mean it probably sounds
really daft, I mean I should be thinking more about my health but I think more about the money aspect of it because I do
enjoy a cigarette. (Woman, 58, negative, not stopped smoking)
Pre-screening decisions
to stop smoking
P5: And I thought this [ECLS study] is just another way of trying to stop so I’m going to go for it and see what happens. I
didn’t know what it was all about then, obviously.
Interviewer: So you thought it could help you to try and stop smoking?
P5: Yep I needed motivation to stop. And you can do with any motivation you can get.
(Man, 62, negative, stopped smoking)
Table 4 Themes in those who did not want to stop smoking
Reassurance from study
schedule CT scans
P14: If they see any changes within the CAT scan it’s gonna be caught at an extremely early stage. If there’s any changes well, I’ll
just cross that bridge when I come to it. (Man, 64, positive, not stopped smoking)
Too late to stop now P19: I suppose at my age lack of motive. I mean I’ve known quite a number of people younger than me have died. I don’t
expect to live that much longer and I’d rather live it pleasantly. (Woman, 74, positive, not stopped smoking)
P14: I think I’ve had a good life and I’ve been here long enough and I think now if it was going to be something serious well,
what would I get out of it? Another 3 or 4 years, you know. I’m not unduly perturbed about it, the prospect. Sad to say.
(Man, 64, positive, not stopped smoking)
Avoidance of thoughts
about smoking
P26: I blank it out my mind, smoking. I blank lung cancer out my mind. (Woman, 57, negative, not stopped smoking)
P22: I think it [smoking] probably is always in my mind but I am a bit of a bury my head in the sand kinda person about it.
(Woman, 59, positive, not stopped smoking)
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to stop smoking or a reason to continue smoking.
Screening was a ‘wake-up call’ to the risks of smoking
and created a sense that ‘now’ was the time to stop
smoking. Family members, age-related factors and the
existence of multiple coinciding non-screening factors
were also influential. The teachable moment was experi-
enced at different stages of the screening process and
some had participated in screening in order to try to
stop smoking. Those who did not want to stop smoking
experienced reassurance from study scans, felt that it
was too late to stop, or avoided thinking about stopping.
Strengths and limitations
Qualitative methods allowed an in-depth and nuanced
exploration of the patient perspective of the topic. There
was a good response rate to study invitations. Rigour
was demonstrated by the inclusion of those who had
received positive and negative test results and those who
had and had not tried to stop smoking, along with the
use of an inductive and deductive approach to analysis.
Reliability was ensured by digital recording and verbatim
transcription of interviews, the use of software to allow
systematic coding, and discussion between two
researchers during the sorting of codes into structures to
generate overarching themes. We demonstrated sensitiv-
ity to context by positioning the study within the wider
ECLS study and through the use of neutral,
non-judgmental language in approaching the topic of
smoking in the invitation materials and interviews [32].
Some limitations should also be considered. Partici-
pants were likely to be more motivated to stop smoking
than the wider smoking population because they had
agreed to take part in a screening study, a nested ques-
tionnaire study and a further qualitative study. Having a
blood sample taken for cancer screening could have
been an unusual experience for them and the results
may be less generalisable to screening programmes in-
volving just CT without a preceding blood screen. Dur-
ing recruitment to the ECLS study, participants were
provided with information about concepts such as ran-
domisation and allocation to the control group, which
can cause confusion [28] and could have inhibited un-
derstanding of other information such as the meaning of
test results. We did not have data on patient
self-reported health-literacy or numeracy to explore
whether this influenced interpretations of test results.
Finally, most participants asked if the interviewer was a
smoker and may have adjusted their explanations about
smoking after learning that this was not the case. The
researcher did, however, take a neutral standpoint on
any issues arising and as a visitor to the study regions
could be distanced from the local ECLS study clinical
processes and engage simply as an interested outside
observer of experiences.
Comparison with other data
Individualistic responses to screening test results can
help explain why, except for those receiving abnormal
results in some studies, consistent patterns in the im-
pact of lung cancer screening on smoking have not
been observed to date. Misinterpretations of the de-
gree of lung cancer risk implied by positive or nega-
tive lung cancer screening results is a novel finding
that highlights complexity in the behavioural impact
of lung cancer screening. It suggests that any change
in motivation for smoking cessation created by lung
cancer screening may sometimes be based on a sub-
optimal understanding of information provided to
screening participants. This provides support for con-
cerns raised about the effects on patients of
Fig. 2 Diagram of themes
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dichotomising cancer screening test results into ‘posi-
tive’ and ‘negative’ [33].
The finding that lung cancer screening test results
are experienced emotionally, and that this can influ-
ence health behaviour, has been reported in previous
work. A qualitative study of CT lung-screened
smokers reported emotional arousal as one of three
key pathways by which screening may influence mo-
tivation around smoking cessation [26]. Abnormal
lung screening results have been shown to have a
short-term adverse impact on emotional outcomes
[34–37] and to promote smoking cessation [38]. Un-
certainty management theory can provide a frame-
work around which to understand the relationship
between emotional and behavioural responses to
screening. Screening test results can change an indi-
viduals’ level of uncertainty about their health, their
appraisal of this uncertainty can elicit a positive or
negative emotional response, which can influence
smoking behaviour [39]. In smokers undergoing lung
cancer screening these emotional responses might
create active or passive dissonance with emotional
responses to smoking behaviours. In this way,
smokers’ motivations and decisions about smoking
are a response to screening resulting from their
appraisal of uncertainty and the emotions that result.
In our participants the uncertainty they experienced
relates to their understanding of screening test re-
sults. Furthermore, their emotional response to uncer-
tainty appraisal can lead to information seeking or
avoidance and in the case of information seeking be-
haviour, this could improve understanding of screen-
ing test results.
The themes ‘wake-up call’ and ‘now is the time to stop
smoking’ support the idea that lung cancer screening
can be a teachable moment for smoking cessation. This
contrasts with evidence from the National Lung Screen-
ing Trial, which reported screening was not a cue to
action and high risk perceptions were not related to
quitting [25]. This may be due to our study adopting a
more in-depth and loosely structured approach to data
collection, allowing the wider context of smoking moti-
vations to be explored. For example, we found when
lung cancer screening played a role in motivations to
stop smoking there were often other important
non-screening factors at play.
Some had taken part in screening in order to try and stop
smoking. This is consistent with a previous qualitative find-
ing that motivation to stop smoking was one of three per-
ceived benefits of lung cancer screening in smokers [40].
We also found some evidence that reassurance from CT
scans could reduce motivation to quit, and that some
people cut down their smoking or made other changes,
both findings that have been reported previously [25, 26].
Implications for research, policy and practice
The polarised way in which screening test results were
sometimes interpreted in our study (very high/very low
risk) was a factor in motivations about smoking. To aid
understanding, ECLS study screening test results were
communicated as ‘positive’ or ‘negative’ along with prob-
abilities using simple frequencies. However, there were
still deficits in understanding, highlighting a need for
further progress in this area to enable better understand-
ing of lung cancer screening tests and test results by par-
ticipants. Research to describe the complexities of
experiences of uncertainty in lung cancer screening
patients who smoke can help to develop communication
processes that facilitate desired behavioural responses in
the management of that uncertainty. This can include
information seeking and smoking quit attempts.
Smokers may experience different emotional responses
and motivations about smoking if they understand their
risk in a different way. It is therefore important that
quantitative studies of the impact of lung cancer screen-
ing on smoking account for levels of perceived risk. Any
assessment of the overall benefits and harms of a lung
screening programme should consider how well test
results are understood and how individuals might react
emotionally and behaviourally to those results. Further-
more, when considering the emotional harms of screen-
ing it should be acknowledged that short-term
emotional harms could promote longer term benefits
such as smoking cessation.
The findings suggest that smoking cessation advice in
lung cancer screening should be tailored according to indi-
vidual interpretations of, and emotional responses to test
results. A randomised trial of male smokers found
computer-tailored advice did not result in significantly dif-
ferent abstinence rates than standardised advice following
lung cancer screening [18]. Importantly, the advice was tai-
lored to smoking attitudes and behaviour but not to under-
standing of and emotional response to screening test
results. A telephone counselling intervention which aimed
to use lung cancer screening test results to increase risk
perceptions was effective at promoting cessation in a pilot
randomised trial [20]. The stated aim of this strategy was to
capitalise on the teachable moment of an abnormal result
and to counteract the potential for reduced motivation to
quit after a result showing no nodules or abnormalities. A
responsive approach such as this, rather than a
computer-tailored method, has the flexibility to adapt the
advice depending on the attitudes and intentions of the in-
dividual, which our study showed can be unpredictable and
individualistic. Such interventions should also be flexible in
the timing of delivery and should be offered after the test
result is delivered so that interpretation of the result can be
explored and emotional responses can be further pursued.
Family members could also be involved and non-screening
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factors addressed. The finding that those who did not want
to stop smoking sometimes felt it was too late to do so re-
quires further exploration to ensure this perception can be
addressed. Further research is needed to explore what type
of cessation support lung cancer screening participants
who smoke would find most acceptable and useful.
Conclusions
Our study demonstrates individualised and complex moti-
vations about smoking among lung cancer screening par-
ticipants and the ways in which lung cancer screening can
create a ‘teachable moment’ in motivations about smok-
ing. Emotional and behavioural responses to test results,
which can be misinterpreted, varied between individuals.
Lung cancer screening presents an opportunity to engage
high risk smokers in cessation attempts but cessation sup-
port may need to be tailored to an individual’s emotional
response to their understanding of their test result and
take account of the range of factors we have identified to
be most effective.
Endnotes
1unique indentifier
2gender
3age (years)
4EarlyCDT-Lung test result
5post-screening smoking cessation as described by par-
ticipants in interviews (stopped smoking/not stopped
smoking)
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